---
document_datetime: 2023-12-04 16:22:30
document_pages: 17
document_pathfilename: www.ema.europa.eu/en/documents/procedural-steps-after/qutenza-epar-procedural-steps-taken-and-scientific-information-after-authorisation_en.pdf
document_name: qutenza-epar-procedural-steps-taken-and-scientific-information-after-authorisation_en.pdf
version: success
processing_time: 14.4751696
conversion_datetime: 2025-12-30 12:31:20.199919
docling_version:
  docling-serve: 1.9.0
  docling-jobkit: 1.8.0
  docling: 2.66.0
  docling-core: 2.57.0
  docling-ibm-models: 3.10.3
  docling-parse: 4.7.2
  python: cpython-313 (3.13.11)
  plaform: macOS-26.2-arm64-arm-64bit-Mach-O
---
## Qutenza

Procedural steps taken and scientific information after the authorisation

| Application number   | Scope                                                                                                                                           | Opinion/ Notification 1 issued on   | Commission Decision Issued 2 / amended on   | Product Information affected 3   | Summary                                                                                                   |
|----------------------|-------------------------------------------------------------------------------------------------------------------------------------------------|-------------------------------------|---------------------------------------------|----------------------------------|-----------------------------------------------------------------------------------------------------------|
| N/0062               | Minor change in labelling or package leaflet not connected with the SPC (Art. 61.3 Notification)                                                | 01/12/2023                          |                                             | PL                               |                                                                                                           |
| II/0060              | Update of sections 4.2 and 5.1 of the SmPC in order to update guidance to healthcare professionals regarding progressive response with repeated | 14/09/2023                          | 18/10/2023                                  | SmPC                             | Update of the SmPC in order to update guidance to healthcare professionals regarding progressive response |

<!-- image -->

<!-- image -->

<div style=\"page-break-after: always\"></div>

|         | treatments. C.I.4 - Change(s) in the SPC, Labelling or PL due to new quality, preclinical, clinical or pharmacovigilance data                                                                                                                                                                                                                                                                                                                                                     |            |            |             | with repeated treatments.   |
|---------|-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|------------|------------|-------------|-----------------------------|
| IB/0061 | B.I.a.1.z - Change in the manufacturer of AS or of a starting material/reagent/intermediate for AS - Other variation                                                                                                                                                                                                                                                                                                                                                              | 09/08/2023 | n/a        |             |                             |
| IB/0059 | B.II.e.1.a.2 - Change in immediate packaging of the finished product - Qualitative and quantitative composition - Semi-solid and non-sterile liquid pharmaceutical forms                                                                                                                                                                                                                                                                                                          | 29/05/2023 | 18/10/2023 | SmPC        |                             |
| II/0057 | Update of sections 4.4 and 4.8 of the SmPC in order to add `Third Degree BurnÂ´ to the list of adverse drug reactions (ADRs) with frequency not known, based on a validated safety signal and post- marketing data; the Package Leaflet is updated accordingly. In addition, the MAH took the opportunity to implement editorial changes to the Package Leaflet. C.I.4 - Change(s) in the SPC, Labelling or PL due to new quality, preclinical, clinical or pharmacovigilance data | 26/04/2023 | 18/10/2023 | SmPC and PL | Not applicable              |
| IB/0058 | B.II.e.1.z - Change in immediate packaging of the finished product - Other variation                                                                                                                                                                                                                                                                                                                                                                                              | 08/03/2023 | n/a        |             |                             |

<div style=\"page-break-after: always\"></div>

| IA/0056           | B.I.b.1.d - Change in the specification parameters and/or limits of an AS, starting material/intermediate/reagent - Deletion of a non- significant specification parameter (e.g. deletion of an obsolete parameter)                                                                    | 07/06/2022   | n/a        |             |                                                                                                                                                                                                                                                                                                                                                                                                                                       |
|-------------------|----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|--------------|------------|-------------|---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| PSUSA/533/2 02105 | Periodic Safety Update EU Single assessment - capsaicin                                                                                                                                                                                                                                | 13/01/2022   | n/a        |             | PRAC Recommendation - maintenance                                                                                                                                                                                                                                                                                                                                                                                                     |
| N/0053            | Minor change in labelling or package leaflet not connected with the SPC (Art. 61.3 Notification)                                                                                                                                                                                       | 21/09/2021   | 18/10/2023 | PL          |                                                                                                                                                                                                                                                                                                                                                                                                                                       |
| IB/0052           | B.I.a.1.z - Change in the manufacturer of AS or of a starting material/reagent/intermediate for AS - Other variation                                                                                                                                                                   | 24/02/2021   | n/a        |             |                                                                                                                                                                                                                                                                                                                                                                                                                                       |
| II/0051/G         | This was an application for a group of variations. C.I.4 - Change(s) in the SPC, Labelling or PL due to new quality, preclinical, clinical or pharmacovigilance data C.I.4 - Change(s) in the SPC, Labelling or PL due to new quality, preclinical, clinical or pharmacovigilance data | 28/01/2021   | 09/07/2021 | SmPC and PL | Based on recent post marketing studies reflecting current Qutenza clinical use and changes in recommendations for opioid prescription for acute pain, SmPC is updated to delete the explicit reference to local pre-treatments used in clinical trials and to opioids. SmPC is also updated to include more detail on unintended exposure to capsaicin. For more information, please refer to the Summary of Product Characteristics. |
| IA/0050/G         | This was an application for a group of variations. A.7 - Administrative change - Deletion of manufacturing sites B.II.b.2.a - Change to importer, batch release arrangements and quality control testing of the FP -                                                                   | 15/09/2020   | n/a        |             |                                                                                                                                                                                                                                                                                                                                                                                                                                       |

<div style=\"page-break-after: always\"></div>

|         | Replacement/addition of a site where batch control/testing takes place                                                                                                                                                                                                                                                                                                                                                                                     |            |            |                        |                                                                                                                                                             |
|---------|------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|------------|------------|------------------------|-------------------------------------------------------------------------------------------------------------------------------------------------------------|
| II/0048 | Update of sections 4.2 and 5.1 of the SmPC in order to amend the posology based on PACE and STRIDE studies. The Package Leaflet is updated accordingly. C.I.4 - Change(s) in the SPC, Labelling or PL due to new quality, preclinical, clinical or pharmacovigilance data                                                                                                                                                                                  | 30/04/2020 | 31/07/2020 | SmPC and PL            | The SmPC section 4.2 and 5.1 have been updated in order to amend the posology based on PACE and STRIDE studies. The Package Leaflet is updated accordingly. |
| II/0049 | Update of section 4.8 of the SmPC in order to update the safety information on adverse reactions frequencies based on latest clinical data pooling; the Package Leaflet is updated accordingly. In addition, the Marketing authorisation holder (MAH) took the opportunity to bring the PI in line with the latest QRD template version. C.I.4 - Change(s) in the SPC, Labelling or PL due to new quality, preclinical, clinical or pharmacovigilance data | 16/07/2020 | 09/07/2021 | SmPC and PL            | Update of section 4.8 of the SmPC to include revised adverse reactions frequencies based on latest clinical data pooling.                                   |
| R/0047  | Renewal of the marketing authorisation.                                                                                                                                                                                                                                                                                                                                                                                                                    | 31/01/2019 | 28/03/2019 | SmPC, Labelling and PL |                                                                                                                                                             |
| IA/0046 | B.I.a.1.f - Change in the manufacturer of AS or of a starting material/reagent/intermediate for AS - Changes to quality control testing arrangements for the AS -replacement or addition of a site where batch control/testing takes place                                                                                                                                                                                                                 | 04/06/2018 | n/a        |                        |                                                                                                                                                             |

<div style=\"page-break-after: always\"></div>

| N/0045            | Minor change in labelling or package leaflet not connected with the SPC (Art. 61.3 Notification)                                                                                                                                                                                                                                                                                              | 24/08/2017   | 09/07/2018   | PL                         |                                   |
|-------------------|-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|--------------|--------------|----------------------------|-----------------------------------|
| IAIN/0044/G       | This was an application for a group of variations. B.II.b.1.a - Replacement or addition of a manufacturing site for the FP - Secondary packaging site B.II.b.2.c.1 - Change to importer, batch release arrangements and quality control testing of the FP - Replacement or addition of a manufacturer responsible for importation and/or batch release - Not including batch control/testing  | 20/07/2017   | 09/07/2018   | Annex II, Labelling and PL |                                   |
| T/0043            | Transfer of Marketing Authorisation                                                                                                                                                                                                                                                                                                                                                           | 13/03/2017   | 04/05/2017   | SmPC, Labelling and PL     |                                   |
| PSUSA/533/2 01605 | Periodic Safety Update EU Single assessment - capsaicin                                                                                                                                                                                                                                                                                                                                       | 12/01/2017   | n/a          |                            | PRAC Recommendation - maintenance |
| IB/0041/G         | This was an application for a group of variations. B.II.b.1.b - Replacement or addition of a manufacturing site for the FP - Primary packaging site B.II.b.1.e - Replacement or addition of a manufacturing site for the FP - Site where any manufacturing operation(s) take place, except batch- release, batch control, primary and secondary packaging, for non-sterile medicinal products | 18/05/2016   | n/a          |                            |                                   |

<div style=\"page-break-after: always\"></div>

<!-- image -->

| B.II.b.3.a - Change in the finished or intermediate in the manufacturing process B.II.b.3.a - Change in the finished or intermediate in the manufacturing process B.II.b.4.a - Change in size ranges) of the finished compared to the originally B.II.e.4.a - Change in container or closure (immediate sterile medicinal products B.III.2.b - Change to comply national pharmacopoeia to comply with an update of the Ph. Eur. or national Member State B.III.2.b - Change to comply national pharmacopoeia to comply with an update of the Ph. Eur. or national Member State B.II.b.2.a - Change to arrangements and quality Replacement/addition of control/testing takes place A.7 - Administrative change manufacturing sites A.7 - Administrative change manufacturing sites B.II.b.2.a - Change to   |
|-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

<div style=\"page-break-after: always\"></div>

|             | Replacement/addition of a site where batch control/testing takes place B.II.d.1.d - Change in the specification parameters and/or limits of the finished product - Deletion of a non-significant specification parameter                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      |            |            |                                  |                                                                       |
|-------------|-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|------------|------------|----------------------------------|-----------------------------------------------------------------------|
| IA/0040     | B.II.e.3.c - Change in test procedure for the immediate packaging of the finished product - Deletion of a test procedure if an alternative test procedure is already authorised                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               | 21/12/2015 | n/a        |                                  |                                                                       |
| II/0039     | Extension of Indication to include treatment of diabetic patients with peripheral neuropathic pain based on the results of studies E05-CL-3004 (STEP) and E05-CL-3002 (PACE) for Qutenza. As a consequence, sections 4.1, 4.2, 4.4, 4.8, 5.1, 5.2, 5.3 and 6.6 of the SmPC have been updated. The Package Leaflet Annex II and Labelling are updated in accordance. In addition, the MAH took the opportunity to update the list of local representatives for Belgium in the Package Leaflet. In addition, the MAH took the opportunity to implement minor editorial changes in the SmPC, Annex II, labelling and Package Leaflet. An updated RMP (version 18.3) has been approved as part of the application. C.I.6.a - Change(s) to therapeutic indication(s) - Addition of a new therapeutic indication or modification of an approved one | 23/07/2015 | 20/08/2015 | SmPC, Annex II, Labelling and PL | Please refer to the scientific discussion Qutenza-H-C-909- H-C-II-39. |
| PSUSA/533/2 | Periodic Safety Update EU Single assessment -                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 | 04/12/2014 | n/a        |                                  | PRAC Recommendation - maintenance                                     |

<div style=\"page-break-after: always\"></div>

| 01405             | capsaicin                                                                                                                                     |            |            |                                  |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     |
|-------------------|-----------------------------------------------------------------------------------------------------------------------------------------------|------------|------------|----------------------------------|---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| II/0037           | C.I.13 - Other variations not specifically covered elsewhere in this Annex which involve the submission of studies to the competent authority | 23/10/2014 | n/a        |                                  |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     |
| IA/0036           | B.II.d.2.a - Change in test procedure for the finished product - Minor changes to an approved test procedure                                  | 27/06/2014 | n/a        |                                  |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     |
| R/0031            | Renewal of the marketing authorisation.                                                                                                       | 20/02/2014 | 23/04/2014 | SmPC, Annex II, Labelling and PL | Based upon the data that have become available since the granting of the initial Marketing Authorisation, the CHMP considers that the benefit-risk balance of Qutenza remains positive, however the Committee requested an additional five year renewal on the basis of the following pharmacovigilance grounds: several safety concerns which could impact on the benefit-risk balance of the product require further evaluation or close monitoring including bradycardia, chest pain, application site reactions, second degree burns, off label use, accidental exposure; further important safety data are expected from on-going post- authorisation studies. |
| IB/0035           | C.I.11.z - Introduction of, or change(s) to, the obligations and conditions of a marketing authorisation, including the RMP - Other variation | 03/04/2014 | n/a        |                                  |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     |
| PSUSA/533/2 01305 | Periodic Safety Update EU Single assessment - capsaicin                                                                                       | 05/12/2013 | n/a        |                                  | PRAC Recommendation - maintenance                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   |
| IA/0034           | B.II.b.2.a - Change to importer, batch release arrangements and quality control testing of the FP -                                           | 12/11/2013 | n/a        |                                  |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     |

<div style=\"page-break-after: always\"></div>

|             | Replacement/addition of a site where batch control/testing takes place                                                                                                                                                                                                                                                                                                                                                                                                              |            |            |                        |                       |
|-------------|-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|------------|------------|------------------------|-----------------------|
| IA/0032     | B.II.d.1.a - Change in the specification parameters and/or limits of the finished product - Tightening of specification limits                                                                                                                                                                                                                                                                                                                                                      | 16/10/2013 | n/a        |                        |                       |
| IAIN/0030   | C.I.z - Changes (Safety/Efficacy) of Human and Veterinary Medicinal Products - Other variation                                                                                                                                                                                                                                                                                                                                                                                      | 01/08/2013 | n/a        |                        |                       |
| IAIN/0029/G | This was an application for a group of variations. C.I.9.b - Changes to an existing pharmacovigilance system as described in the DDPS - Change in the contact details of the QPPV C.I.9.c - Changes to an existing pharmacovigilance system as described in the DDPS - Change of the back-up procedure of the QPPV C.I.9.h - Changes to an existing pharmacovigilance system as described in the DDPS - Other change(s) to the DDPS that does not impact on the operation of system | 07/05/2013 | n/a        |                        | the pharmacovigilance |
| IAIN/0028   | C.I.9.c - Changes to an existing pharmacovigilance system as described in the DDPS - Change of the back-up procedure of the QPPV                                                                                                                                                                                                                                                                                                                                                    | 18/03/2013 | n/a        |                        |                       |
| IAIN/0027   | A.1 - Administrative change - Change in the name and/or address of the MAH                                                                                                                                                                                                                                                                                                                                                                                                          | 27/02/2013 | 12/03/2014 | SmPC, Labelling and PL |                       |

<div style=\"page-break-after: always\"></div>

| IAIN/0026/G   | This was an application for a group of variations.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      | 08/02/2013   | n/a        |                                  |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      |
|---------------|-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|--------------|------------|----------------------------------|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| II/0024       | Update of section 4.2 of the SmPC in order add the possibility to use Qutenza without pre-treatment with a topical anaesthetic or to substitute it for an oral analgesic and to further substantiate current instructions for patch application. The Package Leaflet and Labelling are updated accordingly. In addition, the MAH took the opportunity to update the list of local representatives in the Package Leaflet. Furthermore, the PI is being brought in line with the latest QRD template version 8.1. C.I.4 - Variations related to significant modifications of the SPC due in particular to new quality, pre- clinical, clinical or pharmacovigilance data | 15/11/2012   | 11/03/2013 | SmPC, Annex II, Labelling and PL | Results from study QTZ-EC-0002, a randomized, multi- center, assessor-blinded study of the tolerability of Qutenza when applied after pre-treatment with lidocaine or tramadol in subjects with peripheral neuropathic pain, in combination with post-marketing experience, indicated that in some patients, lidocaine pre-treatment can be either avoided or substituted with oral tramadol with no impact on the patch tolerance and therefore the treatment efficacy. Section 4.2 of the SmPC was updated to allow the treating physician to adapt the care of the patient accordingly. In addition the instructions for patch application were further substantiated to enhance appropriate execution of the complete procedure. |
| IB/0025       | C.I.9.z - Changes to an existing pharmacovigilance system as described in the DDPS - Other variation                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    | 07/09/2012   | n/a        |                                  |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      |
| IAIN/0023/G   | This was an application for a group of variations. C.I.9.a - Changes to an existing pharmacovigilance                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   | 03/02/2012   | n/a        |                                  |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      |

<div style=\"page-break-after: always\"></div>

|           | as described in the DDPS - Change in the QPPV C.I.9.d - Changes to an existing pharmacovigilance system as described in the DDPS - Change in the safety database C.I.9.e - Changes to an existing pharmacovigilance system as described in the DDPS - Changes in the major contractual arrangements with other persons or organisations involved in the fulfilment of pharmacovigilance obligations and described in the DD C.I.9.h - Changes to an existing pharmacovigilance system as described in the DDPS - Other change(s) to the DDPS that does not impact on the operation of the pharmacovigilance system   |            |     | system   |
|-----------|----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|------------|-----|----------|
| IA/0022   | B.II.b.2.a - Change to batch release arrangements and quality control testing of the FP - Replacement or addition of a site where batch control/testing takes place                                                                                                                                                                                                                                                                                                                                                                                                                                                  | 17/01/2012 | n/a |          |
| IA/0021/G | This was an application for a group of variations. B.II.d.2.b - Change in test procedure for the finished product - Deletion of a test procedure if an alternative method is already authorised A.5.b - Administrative change - Change in the name and/or address of a manufacturer of the finished product, including quality control sites (excluding manufacturer for batch release) B.III.2.b - Change to comply with Ph. Eur. or with a                                                                                                                                                                         | 21/11/2011 | n/a |          |

<div style=\"page-break-after: always\"></div>

|           | national pharmacopoeia of a Member State - Change to comply with an update of the relevant monograph of the Ph. Eur. or national pharmacopoeia of a Member State B.II.e.4.a - Change in shape or dimensions of the container or closure (immediate packaging) - Non- sterile medicinal products B.III.2.b - Change to comply with Ph. Eur. or with a national pharmacopoeia of a Member State - Change to comply with an update of the relevant monograph of the Ph. Eur. or national pharmacopoeia of a Member State A.5.b - Administrative change - Change in the name and/or address of a manufacturer of the finished product, including quality control sites (excluding manufacturer for batch release) B.II.e.7.b - Change in supplier of packaging components or devices (when mentioned in the dossier) - Replacement or addition of a supplier A.5.b - Administrative change - Change in the name and/or address of a manufacturer of the finished product, including quality control sites (excluding   |            |     |
|-----------|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|------------|-----|
| IA/0019/G | This was an application for a group of variations. C.I.9.a - Changes to an existing pharmacovigilance system as described in the DDPS - Change in the QPPV C.I.9.b - Changes to an existing pharmacovigilance system as described in the DDPS - Change in the                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      | 07/04/2011 | n/a |

<div style=\"page-break-after: always\"></div>

|           | contact details of the QPPV C.I.9.c - Changes to an existing pharmacovigilance system as described in the DDPS - Change of the back-up procedure of the QPPV C.I.9.h - Changes to an existing pharmacovigilance system as described in the DDPS - Other change(s) to the DDPS that does not impact on the operation of the pharmacovigilance system                                                                                                                 |            |            |                                  |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        |
|-----------|---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|------------|------------|----------------------------------|------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| II/0014   | Update of the SPC section 4.2 to change the description of pre-treatment procedures. In addition the MAH took the opportunity to make a few editorial amendments to the SPC, Annex II, Labelling and Package Leaflet. The addresses of the local representatives have been deleted from the Package Leaflet. C.I.4 - Variations related to significant modifications of the SPC due in particular to new quality, pre- clinical, clinical or pharmacovigilance data | 20/01/2011 | 21/02/2011 | SmPC, Annex II, Labelling and PL | IIn previous studies, mostly topical 4 %Lidocaine was used to provide local analgesia prior to application of Qutenza to enhance the tolerability of the Qutenza treatment procedure. In a new study in post herpetic neuralgia patients (Study C123) the tolerability of an alternative to 4% lidocaine, namely lidocaine (2.5%)/prilocaine (2.5%) cream, was evaluated. The description of pre-treatment procedures in Section 4.2 of the SPC for Qutenza was changed from \"a 4% topical Lidocaine\" to \"topical Lidocaine 4% or Lidocaine (2.5%)/prilocaine (2.5%)\". |
| IB/0018   | B.I.a.1.z - Change in the manufacturer of AS or of a starting material/reagent/intermediate for AS - Other variation                                                                                                                                                                                                                                                                                                                                                | 08/12/2010 | n/a        |                                  |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        |
| IA/0017/G | This was an application for a group of variations. B.I.b.1.c - Change in the specification parameters and/or limits of an AS, starting material/intermediate/reagent - Addition of a new specification parameter to the specification with its                                                                                                                                                                                                                      | 03/12/2010 | n/a        |                                  |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        |

<div style=\"page-break-after: always\"></div>

|           | test method - Change in test procedure for AS or material/reagent/intermediate - Minor to an approved test procedure                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        |            |     | corresponding B.I.b.2.a starting changes   |
|-----------|---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|------------|-----|--------------------------------------------|
| IB/0016   | B.II.d.1.d - Change in the specification parameters and/or limits of the finished product - Deletion of a non-significant specification parameter (e.g. deletion parameter                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  | 12/11/2010 | n/a | of an obsolete                             |
| IA/0015   | A.5.b - Administrative change - Change in the name and/or address of a manufacturer of the finished product, including quality control sites (excluding manufacturer for batch release)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     | 28/10/2010 | n/a |                                            |
| IA/0013/G | This was an application for a group of variations. A.5.b - Administrative change - Change in the name and/or address of a manufacturer of the finished product, including quality control sites (excluding manufacturer for batch release) B.II.d.2.b - Change in test procedure for the finished product - Deletion of a test procedure if an alternative method is already authorised B.II.d.1.d - Change in the specification parameters and/or limits of the finished product - Deletion of a non-significant specification parameter (e.g. deletion of an obsolete parameter B.III.2.b - Change to comply with Ph. Eur. or with a national pharmacopoeia of a Member State - Change to comply with an update of the relevant monograph | 17/09/2010 | n/a |                                            |

<div style=\"page-break-after: always\"></div>

|           | the Ph. Eur. or national pharmacopoeia of a State                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        |            |     |          | of Member                    |
|-----------|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|------------|-----|----------|------------------------------|
| IA/0012/G | This was an application for a group of variations. C.I.9.a - Changes to an existing pharmacovigilance system as described in the DDPS - Change in the QPPV C.I.9.b - Changes to an existing pharmacovigilance system as described in the DDPS - Change in the contact details of the QPPV C.I.9.h - Changes to an existing pharmacovigilance system as described in the DDPS - Other change(s) to the DDPS that does not impact on the operation of                                                                                                                                                                      | 13/08/2010 | n/a | Annex II | the pharmacovigilance system |
| IA/0010/G | This was an application for a group of variations. B.I.a.2.a - Changes in the manufacturing process of the AS - Minor change in the manufacturing process of the AS B.I.b.1.b - Change in the specification parameters and/or limits of an AS, starting material/intermediate/reagent - Tightening of specification limits B.I.b.2.a - Change in test procedure for AS or starting material/reagent/intermediate - Minor changes to an approved test procedure B.III.2.b - Change to comply with Ph. Eur. or with a national pharmacopoeia of a Member State - Change to comply with an update of the relevant monograph | 26/05/2010 | n/a |          |                              |

<div style=\"page-break-after: always\"></div>

|         | of the Ph. Eur. or national pharmacopoeia of a Member State B.I.b.2.a - Change in test procedure for AS or starting material/reagent/intermediate - Minor changes to an approved test procedure   |            |            |                        |                                                                                                                                                                                                                                                |
|---------|---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|------------|------------|------------------------|------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| IA/0009 | B.II.e.6.b - Change in any part of the (primary) packaging material not in contact with the finished product formulation - Change that does not affect the product information                    | 23/04/2010 | n/a        |                        |                                                                                                                                                                                                                                                |
| IA/0008 | B.IV.1.b - Change of a measuring or administration device - Deletion of a device                                                                                                                  | 11/02/2010 | n/a        | SmPC, Labelling and PL |                                                                                                                                                                                                                                                |
| II/0002 | Update of DDPS (Pharmacovigilance) Update of DDPS (Pharmacovigilance)                                                                                                                             | 17/12/2009 | 25/01/2010 | Annex II               | The Detailed Description of the Pharmacovigilance System (DDPS) has been updated in order to reflect the change in Marketing Authorisation Holder. Consequently, Annex II has been to reflect the new version number (5.0) of the agreed DDPS. |
| IB/0004 | IA_38_a_Change in test procedure of finished product - minor change to approved test procedure IB_37_b_Change in the specification of the finished product - add. of new test parameter           | 08/01/2010 | n/a        |                        |                                                                                                                                                                                                                                                |
| IA/0006 | IA_38_a_Change in test procedure of finished product - minor change to approved test procedure                                                                                                    | 22/12/2009 | n/a        |                        |                                                                                                                                                                                                                                                |
| IA/0005 | IA_38_a_Change in test procedure of finished product - minor change to approved test procedure                                                                                                    | 04/12/2009 | n/a        |                        |                                                                                                                                                                                                                                                |

<div style=\"page-break-after: always\"></div>

| IA/0003   | IA_20_a_Change in test procedure for an excipient - minor change to approved test procedure   | 24/11/2009   | n/a        |                        |
|-----------|-----------------------------------------------------------------------------------------------|--------------|------------|------------------------|
| T/0001    | Transfer of Marketing Authorisation                                                           | 08/09/2009   | 25/09/2009 | SmPC, Labelling and PL |